Amneal Pharmaceuticals, LLC
Amneal Pharmaceuticals develops approximately 300 complex generic, specialty, and biosimilar medicines across neurology, endocrinology, and other therapeutic areas.
10-QNov 9Latest SEC filing
Nov 4Latest story
November 2026
October 2026
September 2026
August 2026
July 2026